<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">33580910</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>05</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>05</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1346-8138</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>48</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of dermatology</Title>
          <ISOAbbreviation>J Dermatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Two patients with Papillon-Lefèvre syndrome without periodontal involvement of the permanent dentition.</ArticleTitle>
        <Pagination>
          <StartPage>537</StartPage>
          <EndPage>541</EndPage>
          <MedlinePgn>537-541</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1346-8138.15720</ELocationID>
        <Abstract>
          <AbstractText>Papillon-Lefèvre syndrome (PLS) is a rare autosomal recessive genodermatosis characterized by palmoplantar keratoderma and severe periodontitis leading to premature loss of primary and permanent teeth. PLS is caused by loss-of-function mutations in CTSC, lacking functional cathepsin C, which impairs the activation of neutrophil serine proteases. Precise pathogenesis of periodontal damage is unknown. Patient 1 presented with well-demarcated, transgredient, diffuse, palmoplantar keratoderma and psoriasiform lesions from the age of 2 years. Based on severe and recurrent periodontal inflammation, his dentist had diagnosed PLS at the age of 3 years and provided a strict oral hygiene regimen with repeated adjunct antibiotic therapies. Oral acitretin 10 mg/day along with tretinoin ointment at the age of 9 greatly improved palmoplantar keratoderma. Aged 18 years, the patient exhibited an intact permanent dentition and absence of periodontal disease. Patient 2, a 30-year-old man, suffered from transgredient, diffuse, palmoplantar keratoderma with fissuring from the age of 2 months, marked psoriasiform plaques on elbows and knees, and nail dystrophy. Intriguingly, without specific dental treatment, teeth and dental records were unremarkable. He was referred with a suspected diagnosis of psoriasis. Both patients were otherwise healthy, blood tests and sonography of internal organs were within normal limits. Panel sequencing revealed loss-of-function mutations in CTSC, c.322A&gt;T (p.Lys108Ter) and c.504C&gt;G (p.Tyr168Ter) in patient 1 and homozygous c.415G&gt;T (p.Gly139Ter) in patient 2. The final diagnosis of unusual PLS was made. PLS should be considered in palmoplantar keratoderma lacking periodontitis or tooth loss.</AbstractText>
          <CopyrightInformation>© 2021 Japanese Dermatological Association.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Umlauft</LastName>
            <ForeName>Julian</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-3183-2753</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Venereology and Allergy, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schnabl</LastName>
            <ForeName>Dagmar</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Operative and Restorative Dentistry, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Blunder</LastName>
            <ForeName>Stefan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Venereology and Allergy, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moosbrugger-Martinz</LastName>
            <ForeName>Verena</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Venereology and Allergy, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kapferer-Seebacher</LastName>
            <ForeName>Ines</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Operative and Restorative Dentistry, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zschocke</LastName>
            <ForeName>Johannes</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schmuth</LastName>
            <ForeName>Matthias</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Venereology and Allergy, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gruber</LastName>
            <ForeName>Robert</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">0000-0003-3358-1684</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Venereology and Allergy, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>02</Month>
          <Day>13</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Dermatol</MedlineTA>
        <NlmUniqueID>7600545</NlmUniqueID>
        <ISSNLinking>0385-2407</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 3.4.14.1</RegistryNumber>
          <NameOfSubstance UI="D020789">Cathepsin C</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020789" MajorTopicYN="N">Cathepsin C</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019229" MajorTopicYN="N">Dentition, Permanent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006720" MajorTopicYN="N">Homozygote</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007645" MajorTopicYN="Y">Keratoderma, Palmoplantar</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010214" MajorTopicYN="Y">Papillon-Lefevre Disease</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">CTSC</Keyword>
        <Keyword MajorTopicYN="N">Papillon-Lefèvre syndrome</Keyword>
        <Keyword MajorTopicYN="N">cathepsin C</Keyword>
        <Keyword MajorTopicYN="N">genodermatosis</Keyword>
        <Keyword MajorTopicYN="N">keratoderma</Keyword>
        <Keyword MajorTopicYN="N">periodontitis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>9</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>13</Day>
          <Hour>12</Hour>
          <Minute>6</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33580910</ArticleId>
        <ArticleId IdType="doi">10.1111/1346-8138.15720</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Lefèvre C, Blanchet-Bardon C, Jobard F, Bouadjar B. Novel point mutations, deletions, and polymorphisms in the cathepsin C gene in nine families from Europe and North Africa with Papillon-Lefèvre syndrome. J Invest Dermatol. 2001;117:1657-61.</Citation>
        </Reference>
        <Reference>
          <Citation>Ullbro C, Crossner C-G, Nederfors T, Alfadley A, Thestrup-Pedersen K. Dermatologic and oral findings in a cohort of 47 patients with Papillon-Lefèvre syndrome. J Am Acad Dermatol. 2003;48:345-51.</Citation>
        </Reference>
        <Reference>
          <Citation>Almuneef M, Al Khenaizan S, Al Ajaji S, Al-Anazi A. Pyogenic liver abscess and Papillon-Lefèvre syndrome: not a rare association. Pediatrics 2003;111:e85-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Tekin B, Yucelten D, Beleggia F, Sarig O, Sprecher E. Papillon-Lefèvre syndrome: report of six patients and identification of a novel mutation. Int J Dermatol. 2016;55:898-902.</Citation>
        </Reference>
        <Reference>
          <Citation>Turk D, Janjić V, Stern I, Podobnik M, Lamba D, Weis Dahl S, et al. Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases. EMBO J. 2001;20:6570-82.</Citation>
        </Reference>
        <Reference>
          <Citation>Bullón P, Morillo JM, Thakker N, Veeramachaneni R, Quiles JL, Ramírez-Tortosa MC, et al. Confirmation of oxidative stress and fatty acid disturbances in two further Papillon-Lefèvre syndrome families with identification of a new mutation. J Eur Acad Dermatol Venereol JEADV. 2014;28:1049-56.</Citation>
        </Reference>
        <Reference>
          <Citation>Gelmetti C, Nazzaro V, Cerri D, Fracasso L. Long-term preservation of permanent teeth in a patient with Papillon-Lefevre Syndrome treated with etretinate. Pediatr Dermatol. 1989;6:222-5.</Citation>
        </Reference>
        <Reference>
          <Citation>Wiebe CB, Häkkinen L, Putnins EE, Walsh P, Larjava HS. Successful periodontal maintenance of a case with Papillon-lefévre Syndrome: 12-year follow-up and review of the literature. J Periodontol. 2001;72:824-30.</Citation>
        </Reference>
        <Reference>
          <Citation>Pacheco JJ, Coelho C, Salazar F, Contreras A, Slots J, Velazco CH, et al. Treatment of Papillon-Lefèvre syndrome periodontitis. J Clin Periodontol. 2002;29:370-4.</Citation>
        </Reference>
        <Reference>
          <Citation>Hahn J, Schauer C, Czegley C, Kling L, Petru L, Schmid B, et al. Aggregated neutrophil extracellular traps resolve inflammation by proteolysis of cytokines and chemokines and protection from antiproteases. FASEB J. 2019;33:1401-14.</Citation>
        </Reference>
        <Reference>
          <Citation>Eick S, , Puklo M, Adamowicz K, , Kantyka T, Hiemstra P, Stennicke H, et al. Lack of cathelicidin processing in Papillon-Lefèvre syndrome patients reveals essential role of LL-37 in periodontal homeostasis. Orphanet J Rare Dis. 2014;9:148.</Citation>
        </Reference>
        <Reference>
          <Citation>Eickholz P, Kugel B, Pohl S, Näher H, Staehle HJ. Combined mechanical and antibiotic periodontal therapy in a case of Papillon-Lefèvre Syndrome. J Periodontol. 2001;72:542-9.</Citation>
        </Reference>
        <Reference>
          <Citation>Nickles K, Schacher B, Schuster G, Valesky E, Eickholz P. Evaluation of two siblings with Papillon-Lefèvre Syndrome 5 years after treatment of periodontitis in primary and mixed dentition. J Periodontol. 2011;82:1536-47.</Citation>
        </Reference>
        <Reference>
          <Citation>Kressin S, Herforth A, Preis S, Wahn V, Lenard HG. Papillon-Lefèvre syndrome-successful treatment with a combination of retinoid and concurrent systematic periodontal therapy: case reports. Quintessence Int Berl Ger. 1995;1985(26):795-803.</Citation>
        </Reference>
        <Reference>
          <Citation>Rey T, Tarabeux J, Gerard B, Delbarre M, Le Bechec A, Stoetzel C, et al. Protocol GenoDENT: implementation of a new NGS panel for molecular diagnosis of genetic disorders with orodental involvement. Methods Mol Biol Clifton NJ. 2019;1922:407-52..</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
